Latest news with #EvaPharma
Libya Review
3 days ago
- Health
- Libya Review
Benghazi University Hosts Free Screenings for Blood Pressure Day
Benghazi International University (BIU), in collaboration with Eva Pharma and its School of Nursing Sciences, along with the University Medical Center, hosted a public awareness event on Thursday to mark World Hypertension Day. The event aimed to raise awareness about the dangers of high blood pressure—often referred to as the 'silent killer'—and to promote preventive healthcare within the local community. Speaking at the event, University Dean Dr. Mohamed Saad emphasized the critical importance of the day, highlighting the prevalence and serious health risks posed by hypertension. 'This is one of the most widespread and dangerous chronic diseases, and it often goes undetected until it causes major harm. Raising awareness about prevention, healthy diets, regular physical activity, and consistent medical monitoring is essential,' he stated. Dr. Saad noted that the initiative reflects the university's ongoing commitment to community engagement and public health education. He added that the program brought together both academic and medical professionals to offer practical knowledge and services to the public. The event featured free blood pressure screenings, educational lectures, expert advice on nutrition and prevention, and informational pamphlets for students and visitors. This campaign is part of a broader effort by the university to support health literacy and community wellbeing in Benghazi and beyond. Libya has been in chaos since a NATO-backed uprising toppled longtime leader Muammar Gaddafi in 2011. The county has for years been split between rival administrations. Libya's economy, heavily reliant on oil, has suffered due to the ongoing conflict. The instability has led to fluctuations in oil production and prices, impacting the global oil market and Libya's economy. The conflict has led to a significant humanitarian crisis in Libya, with thousands of people killed, and many more displaced. Migrants and refugees using Libya as a transit point to Europe have also faced dire conditions. The planned elections for December 2021 were delayed due to disagreements over election laws and the eligibility of certain candidates. This delay has raised concerns about the feasibility of a peaceful political transition. Despite the ceasefire, security remains a significant concern with sporadic fighting and the presence of mercenaries and foreign fighters. The unification of the military and the removal of foreign forces are crucial challenges.
Daily News Egypt
11-03-2025
- Health
- Daily News Egypt
Egypt among first nations to launch national strategy against antimicrobial resistance: Health Minister
Egypt's Deputy Prime Minister and Minister of Health, Khaled Abdel Ghaffar, emphasized that antimicrobial resistance (AMR) is not merely a medical issue but a global crisis requiring a coordinated, multi-sectoral response. Speaking at the Second National Conference on Infection Control and Antimicrobial Resistance, held in cooperation with Sanofi and Eva Pharma, Abdel Ghaffar highlighted Egypt's proactive approach in tackling this challenge, noting that the country was among the first to launch a National Strategy to Combat Antimicrobial Resistance in 2018. The minister commended the Preventive Medicine Sector at the ministry, alongside key partners, for their contributions to strengthening the health system. He warned that if urgent action is not taken, AMR could lead to 10 million deaths annually by 2050, placing immense pressure on global healthcare systems. Despite challenges posed by the COVID-19 pandemic, Egypt advanced its efforts by launching the National Antimicrobial Control Plan in May 2023. This initiative established antimicrobial resistance control programs in at least one hospital per governorate, with a goal of including 80 hospitals by 2025. Infection control programs have also been reinforced nationwide, with all Ministry of Health-affiliated hospitals evaluated. The current compliance rate for infection control measures stands at 64.2%, with corrective actions planned for underperforming hospitals. During the conference, Ali Al-Ghamrawi, Head of the Egyptian Drug Authority, underscored Egypt's significant progress in the medical sector, affirming that the country is on a steady path toward expanding and improving healthcare services. He noted that the Egyptian pharmaceutical market, valued at EGP 308bn, is one of the largest in the region, with more than 12,000 pharmaceutical preparations available and total sales reaching 3.6 billion packages. Antimicrobials constitute 887 registered pharmaceutical products, with total sales of 376 million packages, accounting for 10% of total pharmaceutical market sales. Alarmingly, 55% of all antibiotic sales occur without a prescription, highlighting the urgent need for stricter regulations and awareness campaigns to curb misuse and prevent further resistance. Egypt's efforts in antimicrobial resistance management reflect a broader national commitment to public health, pharmaceutical regulation, and sustainable healthcare development. The country continues to push forward with targeted strategies to mitigate the risks of drug-resistant infections and ensure the effectiveness of antibiotics for future generations.
